醫(yī)學全在線
搜索更多精品課程:
熱 門:外科內科學婦產(chǎn)科兒科眼科耳鼻咽喉皮膚性病學骨科學全科醫(yī)學醫(yī)學免疫學生理學病理學診斷學急診醫(yī)學傳染病學醫(yī)學影像藥 學:藥理學藥物化學藥物分析藥物毒理學生物技術制藥生藥學中藥學藥用植物學方劑學衛(wèi)生毒理學檢 驗:理化檢驗 臨床檢驗基礎護 理:外科護理婦產(chǎn)科護理兒科護理 社區(qū)護理五官護理護理學內科護理護理管理學中 醫(yī):中醫(yī)基礎理論中醫(yī)學針灸學刺法灸法學口 腔:口腔內科口腔外科口腔正畸口腔修復口腔組織病理生物化學:生物化學細胞生物學病原生物學醫(yī)學生物學分析化學醫(yī)用化學其 它:人體解剖學衛(wèi)生統(tǒng)計學人體寄生蟲學儀器分析健康評估流行病學臨床麻醉學社會心理學康復醫(yī)學法醫(yī)學核醫(yī)學危重病學中國醫(yī)史學
您現(xiàn)在的位置: 醫(yī)學全在線 > 精品課程 > 藥理學 > 南華大學 > 正文:藥理學授課教案:第二十三章 腎素-血管緊張素系統(tǒng)藥理
    

藥理學授課教案-第四篇 心血管系統(tǒng)藥理:第二十三章 腎素-血管緊張素系統(tǒng)藥理

藥理學授課教案第四篇 心血管系統(tǒng)藥理:第二十三章 腎素-血管緊張素系統(tǒng)藥理:生命科學與技術學院教 案 首 頁教研室:藥理學教師姓名:歐和生 課 程名 稱 藥理學 授課專業(yè)及班次 臨床醫(yī)學專業(yè) 授課內 容 腎素-血管緊張素系統(tǒng)藥理 授課方式 授課時數(shù) 理論講授 2學時 目 的 要 求 1. 熟悉腎素-血管緊張素系統(tǒng)對心血管系統(tǒng)的生理機制。 2.

生命科學與技術學院

教 案 首 頁

教研室:藥理學  教師姓名:歐和生

課 程名 稱

藥理學

授課專業(yè)及班次

臨床醫(yī)學專業(yè)

授課內 容

腎素-血管緊張素系統(tǒng)藥理

授課方式

授課時數(shù)

理論講授

2學時

1. 熟悉腎素-血管緊張素系統(tǒng)對心血管系統(tǒng)的生理機制。
2. 掌握ACEI和血管緊張素II受體I型阻滯劑的藥理作用及其機制。
3. 掌握卡托普利氯沙坦的藥理作用、臨床應用及主要不良反應。

重點

1. ACEI和血管緊張素II受體I型阻滯劑的藥理作用及其機制。

2. 托普利和氯沙坦等藥物的藥理作用、臨床應用。

難點

腎素-血管緊張素系統(tǒng)對心血管系統(tǒng)調節(jié)的生理機制及藥物作用機制。

授課內容及時間分配

1.   Renin-Aangiotensin-System (20 分鐘)

2.   Angiotensin converting enzyme inhibitors (ACEI) (45分鐘)

3.   The blockade of angiotension II receptor (20 分鐘)

4.   小結、布置思考題、安排下次課內容 (5分鐘)

教具教材

多媒體加版書

教材:楊寶峰 主編:藥理學 人民衛(wèi)生出版社,北京,2003年

網(wǎng)

1.  周宏灝主編:藥理學 科學出版社,北京,2003年

2.  Pharmacology : 天津醫(yī)科大學藥理教研室主編,1999年

3.  H.P. Rang, M.M Dale, J.M. Ritter P.K. Moore. Pharmacology ( the fifth edition). 2003.


Part 1  Renin-Aangiotensin-System

 

Introduction

1.Element of RAS (renin, angiotensinogen,angiotensin, ACE, ATR)

Renin is an enzyme that acts on angiotensinogen to catalyze the formation of the decapeptide angiotensin I.

Angiotensin I is then cleaved by ACE to yield the octapeptide angiotensin II.

ATR: AT1R, AT2R

2.The regulation effect of RAS on blood pressure

The renin-angiotensinsystem is an important participant in both the short-and long-term regulationof arterial blood pressure.

Angiotensin II acts in several ways to increase totalperipheral resistance and thereby contributes to the short-term regulation ofarterial blood pressure. Perhaps the more important is the ability of angiotensin II to inhibit excretion of Na+ and water by thekidneys.

Angiotensin II – induced changes in renal functionplay an important role in long-term stabilization of arterial blood pressure.

Part 2  Angiotensinconverting enzyme inhibitors (ACEI)

1.Pharmacological effects

(1) Inhibit the formation of Ang II.

 (2) Maintain the activity of brandykinin (BK).

 (3) Protection of endothelium andanti-atherosclerosis

 (4) Anti-iscamiaand protection of myocardial cell

 (5) Increase the sensitivity of insulin

(6) Inhibit the pathological cardiovascular remodeling

2. Clinical uses

(1) Hypertension

(2) CHF and myocardial infarction

(3) DMEM and nephropathy

3. Untoward effects

(1) Hypotension: occurring in the first use.

(2) Cough: of 6 ~ 12%

(3) Hyperkalemia

(4) Low blood sugar

(5) Renal function trauma

(6) Affection of the development of fetus and newborn.

(7) Neuro Oedema.

(8) Malfunction of taste, tetter (thedrugs with –SH).

4.The drugs of ACEI.

. Captopril

Pharmacological Action :

 i  Directly inhibited ACE. (IC50:23 ~ 35 nmol /L), The depressor effect associated with the activitystate of RAS.

ii   The protection of heart is relatedto abolishing of ROS, such as iscamia.

Pharmacokinetics

o  Absorption : Po, F=75%. Taction :30 min. Tmax=1h.

o  Distribution: extensivelydistributed in body , Pb=30%.

o  Metabolism: oxygen in –SH.

o  Excretion: from kidney: 40-50%in parent drug and the others in metabolites.

Clinical uses

o  Hypertension: single or combination.

o  CHF

o  Cardiac infarct.

o  DMEM-nephropathy (only captopril).

Untoward effects

Apart fromthe common side effect, cough is usually complaint.

Enalapril

o  Action : the action of inhibition of ACE is 10 times stronger than captopril.

o  The absorption is not affectedby food. Po. TP=4-6h.  Tmaintain=24h,q.d.

o  Metabolism: enalaprilat(MK22)

o  Distribution extensively inbody. T1/2: 11h.

o  Excretion from kidney.

o  Uses: hypertensiongydjdsj.org.cn/sanji/ and CHF.

o  Aside effect: cough ,hypotension, hyperkalemiaetc.

Fosinopril

o  Prodrug (poo-): fosinoprilacid is the activity chemical.

o  Tp=3-6 h

o  Pb=95%

o&gydjdsj.org.cn/kuaiji/nbsp; T1/2=12h

o  Distribution : heart and brain(much)

o  Excretion: from liver and kidney,  no toxicityaccumulation for light malfunction of kidney.

o  No use:lactation

Lisinopril

benazepril

Part 3  The blockade of angiotension II receptor

losartan、valsartan、erbesartan、candesartan、tasosartan、eprosartan、telmisartan

1. Pharmacological effects and mechanism

 (1) Block the AT1R   vasodilatation 

     Aldostrone  Hypotension

 


(2) Block theAT1R Renin  AngII AT2RBK-NO 

Vasodilatation, regression of remodeling Hypotension.

Losartan

1.Pharmacological effects

(1)AT1R: Losartan block AT1R>AT2R (2-3萬倍).   EXP3174 >losartanin  blocking  AT1R  (10- 40 times)

(2)Vasodilate renalartery, decrease reabsorption of water and Na+in renal tube.

(3)Protect kidney:Hypertension,DM and failure of kidney.

(4)Inhibit vascular remodeling.

2. Clinical uses

 (1) Hypertension

 (2)CHF

3. Untoward effects: less than ACEI, avoid use with low efficacy diuretics.

Part 4 Howabout combination of AT1Ranta and ACEI

  1. Increase effects(cure in hypertension, CHF), decrease disadvantage of the two class drugs.

  2. Have not found anyadverse effects

Questions:

1. Describe the advantages anddisadvantages of AT1R and ACEI in therapeutics of hypertension.

2. what is thecommon side effect of Captopril?

...
關于我們 - 聯(lián)系我們 -版權申明 -誠聘英才 - 網(wǎng)站地圖 - 醫(yī)學論壇 - 醫(yī)學博客 - 網(wǎng)絡課程 - 幫助
醫(yī)學全在線 版權所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
皖ICP備06007007號
百度大聯(lián)盟認證綠色會員可信網(wǎng)站 中網(wǎng)驗證